Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Sophia C Kamran, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
Massachusetts Institute of Technology, Cambridge, MABSBiological Engineering/Biology
Harvard Medical School, Boston, MAMD
Memorial Sloan Kettering Cancer Center, New York, NYInternship
Harvard Radiation Oncology Program, Boston, MAResidencyRadiation Oncology

Overview

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Salinas KE, Nguyen HB, Kamran SC. The invisible minority: A call to address the persistent socioeconomic diversity gap in U.S. medical schools and the physician workforce. Front Public Health. 2022; 10:924746. PMID: 35968485.
    Citations:    
  2. Burgess L, Aldrighetti CM, Ghosh A, Niemierko A, Chino F, Huynh MJ, Efstathiou JA, Kamran SC. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality. JAMA Netw Open. 2022 05 02; 5(5):e2211869. PMID: 35576008; PMCID: PMC9112070.
    Citations:    Fields:    Translation:HumansPHPublic Health
  3. Kamran SC, Winkfield KM, Reede JY, Vapiwala N. Intersectional Analysis of U.S. Medical Faculty Diversity over Four Decades. N Engl J Med. 2022 04 07; 386(14):1363-1371. PMID: 35388674.
    Citations:    Fields:    Translation:Humans
  4. Kishan AU, Kamran SC, Soerensen SJC, Leppert JT. Dual X-ray Absorptiometry Screening for Men Receiving Androgen Deprivation Therapy-Hiding in Plain (Film) Sight. JAMA Netw Open. 2022 04 01; 5(4):e225439. PMID: 35363273.
    Citations:    Fields:    Translation:Humans
  5. Kamran SC, Niemierko A, Deville C, Vapiwala N. Diversity Trends by Sex and Underrepresented in Medicine Status Among US Radiation and Medical Oncology Faculty Over 5 Decades. JAMA Oncol. 2022 Feb 01; 8(2):221-229. PMID: 34882189; PMCID: PMC8662536.
    Citations: 1     Fields:    Translation:Humans
  6. Kamran SC, Gao X. Solving the Stereotactic Body Radiotherapy and Checkpoint Inhibitor Puzzle in Metastatic Renal Cell Carcinoma. Eur Urol. 2022 03; 81(3):283-284. PMID: 34742587.
    Citations:    Fields:    Translation:Humans
  7. Kamran SC, Xie J, Cheung ATM, Mavura MY, Song H, Palapattu EL, Madej J, Gusev A, Van Allen EM, Huang FW. Tumor Mutations Across Racial Groups in a Real-World Data Registry. JCO Precis Oncol. 2021 11; 5:1654-1658. PMID: 34994651.
    Citations:    Fields:    Translation:Humans
  8. Aldrighetti CM, Niemierko A, Van Allen E, Willers H, Kamran SC. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies. JAMA Netw Open. 2021 11 01; 4(11):e2133205. PMID: 34748007; PMCID: PMC8576580.
    Citations: 2     Fields:    Translation:Humans
  9. Tochigi T, Kamran SC, Parakh A, Noda Y, Ganeshan B, Blaszkowsky LS, Ryan DP, Allen JN, Berger DL, Wo JY, Hong TS, Kambadakone A. Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis. Eur Radiol. 2022 Apr; 32(4):2426-2436. PMID: 34643781.
    Citations:    Fields:    Translation:Humans
  10. Kamran SC, McClatchy DM, Pursley J, Trofimov AV, Remillard K, Saraf A, Ghosh A, Thabet A, Sutphin P, Miyamoto DT, Efstathiou JA. Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy. Pract Radiat Oncol. 2022 Mar-Apr; 12(2):135-144. PMID: 34619374.
    Citations: 1     Fields:    Translation:Humans
  11. Reardon B, Moore ND, Moore NS, Kofman E, AlDubayan SH, Cheung ATM, Conway J, Elmarakeby H, Imamovic A, Kamran SC, Keenan T, Keliher D, Konieczkowski DJ, Liu D, Mouw KW, Park J, Vokes NI, Dietlein F, Van Allen EM. Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. Nat Cancer. 2021 10; 2(10):1102-1112. PMID: 35121878; PMCID: PMC9082009.
    Citations: 2     Translation:Humans
  12. Slevin F, Aitken K, Alongi F, Arcangeli S, Chadwick E, Chang AR, Cheung P, Crane C, Guckenberger M, Jereczek-Fossa BA, Kamran SC, Kinj R, Loi M, Mahadevan A, Massaccesi M, Mendez LC, Muirhead R, Pasquier D, Pontoriero A, Spratt DE, Tsang YM, Zelefsky MJ, Lilley J, Dickinson P, Hawkins MA, Henry AM, Murray LJ. An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation. Radiother Oncol. 2021 11; 164:104-114. PMID: 34560186.
    Citations:    Fields:    Translation:Humans
  13. Kamran SC, Zietman AL. Radiation treatment in prostate cancer: covering the waterfront. BJU Int. 2021 10; 128(4):398-407. PMID: 34273237.
    Citations:    Fields:    Translation:Humans
  14. Ng TSC, Gao X, Salari K, Zlatev DV, Heidari P, Kamran SC. Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective. Front Oncol. 2021; 11:722277. PMID: 34395293; PMCID: PMC8355555.
    Citations:    
  15. Efstathiou JA, Kamran SC, Spratt DE. Protons Versus Photons for Prostate Cancer: An Answer That Is Long Overdue and Coming. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1098-1100. PMID: 34171235.
    Citations: 2     Fields:    Translation:Humans
  16. Kamran SC. When Less is More for Postprostatectomy Salvage Radiotherapy. Eur Urol. 2021 09; 80(3):316-318. PMID: 34246518.
    Citations:    Fields:    Translation:Humans
  17. Kamran SC, Palma D, Katz MS, Zietman AL. Technical Giants But Biologic Infants: Defining a More Sophisticated Role for Local Therapy in Metastatic Disease. Semin Radiat Oncol. 2021 07; 31(3):200-204. PMID: 34090646.
    Citations:    Fields:    Translation:Humans
  18. Marcondes FO, Cheng D, Warner ET, Kamran SC, Haas JS. The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis. Prev Med. 2021 10; 151:106640. PMID: 34217419; PMCID: PMC8262076.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  19. Kamran SC, Yeap BY, Ulysse CA, Cronin C, Bowes CL, Durgin B, Gainor JF, Khandekar MJ, Tansky JY, Keane FK, Olsen CC, Willers H. Assessment of a Contralateral Esophagus-Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation: A Phase 1 Nonrandomized Clinical Trial. JAMA Oncol. 2021 Jun 01; 7(6):910-914. PMID: 33830168; PMCID: PMC8033505.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  20. Kamran SC, Efstathiou JA. Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine. Front Oncol. 2021; 11:675311. PMID: 34026653.
    Citations: 4     
  21. Daye D, Tabari A, Kim H, Chang K, Kamran SC, Hong TS, Kalpathy-Cramer J, Gee MS. Quantitative tumor heterogeneity MRI profiling improves machine learning-based prognostication in patients with metastatic colon cancer. Eur Radiol. 2021 Aug; 31(8):5759-5767. PMID: 33454799.
    Citations: 3     Fields:    Translation:Humans
  22. Kamran SC, Yerramilli D, Vapiwala N. No Talent Left Behind: A Silver Lining for Diversity in Radiation Oncology in the Post-Coronavirus Disease 2019 (COVID-19) Era. Int J Radiat Oncol Biol Phys. 2020 Oct 01; 108(2):472-474. PMID: 32890536.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  23. Kamran SC, Zietman AL. Curing Metastatic Disease With Ablative Radiation Therapy: Separating Truth From Wish. Int J Radiat Oncol Biol Phys. 2020 07 01; 107(3):433-436. PMID: 32531389.
    Citations: 1     Fields:    Translation:Humans
  24. Kamran SC, Zelefsky M, Nguyen PL, Lawton CAF. To Radiate or Not to Radiate-The Challenges of Pelvic Reirradiation. Semin Radiat Oncol. 2020 Jul; 30(3):238-241. PMID: 32503789.
    Citations:    Fields:    Translation:Humans
  25. Kamran SC, Coroller T, Milani N, Agrawal V, Baldini EH, Chen AB, Johnson BE, Kozono D, Franco I, Chopra N, Zeleznik R, Aerts HJWL, Mak R. The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer. Radiat Oncol. 2020 Jan 14; 15(1):14. PMID: 31937336.
    Citations: 2     Fields:    Translation:Humans
  26. Kamran SC, D'Amico AV. Radiation Therapy for Prostate Cancer. Hematol Oncol Clin North Am. 2020 02; 34(1):45-69. PMID: 31739952.
    Citations: 8     Fields:    Translation:Humans
  27. Willers H, Keane FK, Kamran SC. Toward a New Framework for Clinical Radiation Biology. Hematol Oncol Clin North Am. 2019 12; 33(6):929-945. PMID: 31668212.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  28. Kamran SC, Lennerz JK, Margolis CA, Liu D, Reardon B, Wankowicz SA, Van Seventer EE, Tracy A, Wo JY, Carter SL, Willers H, Corcoran RB, Hong TS, Van Allen EM. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer. Clin Cancer Res. 2019 09 15; 25(18):5561-5571. PMID: 31253631; PMCID: PMC6744983.
    Citations: 26     Fields:    Translation:HumansCells
  29. Grassberger C, McClatchy D, Geng C, Kamran SC, Fintelmann F, Maruvka YE, Piotrowska Z, Willers H, Sequist LV, Hata AN, Paganetti H. Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies. Cancer Res. 2019 07 15; 79(14):3776-3788. PMID: 31113818; PMCID: PMC6635042.
    Citations: 13     Fields:    Translation:Humans
  30. Kamran SC, Light JO, Efstathiou JA. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care. Prostate Cancer Prostatic Dis. 2019 12; 22(4):509-521. PMID: 30967625.
    Citations: 9     Fields:    Translation:Humans
  31. Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, Shih HA. Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy. Pract Radiat Oncol. 2019 Jul - Aug; 9(4):e356-e361. PMID: 30790717.
    Citations: 3     Fields:    Translation:Humans
  32. Kamran SC, Qureshi MM, Truong MT. In response to Letter to the Editor regarding: Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope. 2019 03; 129(3):E88-E90. PMID: 30548604.
    Citations:    Fields:    Translation:Humans
  33. Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. J Neurooncol. 2019 Mar; 142(1):69-77. PMID: 30488294.
    Citations: 12     Fields:    Translation:Humans
  34. Kamran SC, Goldberg SI, Kuhlthau KA, Lawell MP, Weyman EA, Gallotto SL, Hess CB, Huang MS, Friedmann AM, Abrams AN, MacDonald SM, Pulsifer MB, Tarbell NJ, Ebb DH, Yock TI. Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up. Cancer. 2018 08; 124(16):3390-3400. PMID: 29905942.
    Citations: 8     Fields:    Translation:Humans
  35. Kamran SC, Clark JW, Zheng H, Borger DR, Blaszkowsky LS, Allen JN, Kwak EL, Wo JY, Parikh AR, Nipp RD, Murphy JE, Goyal L, Zhu AX, Iafrate AJ, Corcoran RB, Ryan DP, Hong TS. Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis. Cancer Med. 2018 May 17. PMID: 29771009.
    Citations: 12     Fields:    
  36. Kamran SC, Mouw KW. Applying Precision Oncology Principles in Radiation Oncology. JCO Precis Oncol. 2018; 2. PMID: 32914000; PMCID: PMC7446508.
    Citations: 4     Fields:    
  37. Kirke DN, Qureshi MM, Kamran SC, Ezzat W, Jalisi S, Salama A, Everett PC, Truong MT. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis. Head Neck. 2018 06; 40(6):1174-1184. PMID: 29417687.
    Citations: 3     Fields:    Translation:Humans
  38. Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ. Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70. Eur Urol. 2018 04; 73(4):e96-e97. PMID: 29358058.
    Citations:    Fields:    Translation:Humans
  39. Seisen T, Kamran SC, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ. Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70. Eur Urol. 2018 04; 73(4):e100-e101. PMID: 29108659.
    Citations:    Fields:    Translation:Humans
  40. Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT. Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope. 2018 06; 128(6):1353-1364. PMID: 28988426.
    Citations: 3     Fields:    Translation:HumansCells
  41. Kamran SC, Jacene HA, Chen YH, Mauch PM, Ng AK. Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD?×?two cycles followed by FDG-PET/CT restaging and 20?Gy of involved-site radiotherapy. Leuk Lymphoma. 2018 06; 59(6):1384-1390. PMID: 28937297.
    Citations: 3     Fields:    Translation:Humans
  42. Kamran SC, Manuel MM, Catalano P, Cho L, Damato AL, Lee LJ, Schmidt EJ, Viswanathan AN. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer. Brachytherapy. 2017 Nov - Dec; 16(6):1159-1168. PMID: 28823395.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  43. Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol. 2018 02; 73(2):262-270. PMID: 28687143.
    Citations: 7     Fields:    Translation:Humans
  44. Kamran SC, Manuel MM, Cho LP, Damato AL, Schmidt EJ, Tempany C, Cormack RA, Viswanathan AN. Corrigendum to "comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix" [Gynecol. Oncol. 145 (2017) 284-290]. Gynecol Oncol. 2017 08; 146(2):440. PMID: 28577883; PMCID: PMC5546914.
    Citations:    Fields:    
  45. Kamran SC, Manuel MM, Cho LP, Damato AL, Schmidt EJ, Tempany C, Cormack RA, Viswanathan AN. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix. Gynecol Oncol. 2017 05; 145(2):284-290. PMID: 28318644; PMCID: PMC5422203.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  46. Kamran SC, Harshman LC, Bhagwat MS, Muralidhar V, Nguyen PL, Martin NE, La Follette S, Faso S, Viswanathan AN, Efstathiou JA, Beard CJ. Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experience. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):140-147. PMID: 28740925; PMCID: PMC5514247.
    Citations: 3     
  47. Kamran SC, Berrington de Gonzalez A, Ng A, Haas-Kogan D, Viswanathan AN. Therapeutic radiation and the potential risk of second malignancies. Cancer. 2016 Jun 15; 122(12):1809-21. PMID: 26950597.
    Citations: 25     Fields:    Translation:Humans
  48. Kamran SC, Hong TS, Wo JY. Advances in the Management of Gastric and Gastroesophageal Cancers. Curr Oncol Rep. 2016 Feb; 18(2):13. PMID: 26769118.
    Citations: 5     Fields:    Translation:Humans
  49. Kamran SC, Mueller BS, Paetzold P, Dunlap J, Niemierko A, Bortfeld T, Willers H, Craft D. Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients. Radiother Oncol. 2016 Mar; 118(3):515-20. PMID: 26830694.
    Citations: 12     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  50. Guda S, Brendel C, Renella R, Du P, Bauer DE, Canver MC, Grenier JK, Grimson AW, Kamran SC, Thornton J, de Boer H, Root DE, Milsom MD, Orkin SH, Gregory RI, Williams DA. miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction. Mol Ther. 2015 Sep; 23(9):1465-74. PMID: 26080908; PMCID: PMC4817887.
    Citations: 48     Fields:    Translation:HumansAnimalsCells
  51. Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 2015 Jul; 24(3):547-61. PMID: 25979399.
    Citations: 61     Fields:    Translation:HumansCells
  52. Kamran SC, Collier JM, Lane AM, Kim I, Niemierko A, Chen YL, MacDonald SM, Munzenrider JE, Gragoudas E, Shih HA. Outcomes of proton therapy for the treatment of uveal metastases. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1044-50. PMID: 25442038.
    Citations: 2     Fields:    Translation:Humans
  53. Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, Shao Z, Canver MC, Smith EC, Pinello L, Sabo PJ, Vierstra J, Voit RA, Yuan GC, Porteus MH, Stamatoyannopoulos JA, Lettre G, Orkin SH. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013 Oct 11; 342(6155):253-7. PMID: 24115442.
    Citations: 269     Fields:    Translation:HumansAnimalsCells
  54. Kamran SC, Shinagare AB, Howard SA, Nishino M, Hornick JL, Krajewski KM, Ramaiya NH. Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management. Radiol Oncol. 2013; 47(3):230-8. PMID: 24133387.
    Citations: 7     Fields:    
  55. Kamran SC, Pendergraft WF, Harmon DC, Rubin MF. Ifosfamide-induced Fanconi syndrome and desmopressin-responsive nephrogenic diabetes insipidus. Am J Med. 2013 Jul; 126(7):e7-8. PMID: 23684064.
    Citations: 2     Fields:    Translation:Humans
  56. Klein JD, Turner CG, Kamran SC, Yu AY, Ferrari L, Zurakowski D, Fauza DO. Pediatric postoperative intussusception in the minimally invasive surgery era: a 13-year, single center experience. J Am Coll Surg. 2013 Jun; 216(6):1089-93. PMID: 23571141.
    Citations: 4     Fields:    Translation:Humans
  57. Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD, Pou K, Larsen PR, Alexander EK. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013 Feb; 98(2):564-70. PMID: 23275525.
    Citations: 64     Fields:    Translation:Humans
  58. Kamran SC, Shinagare AB, Howard SA, Hornick JL, Ramaiya NH. A-Z of malignant peripheral nerve sheath tumors. Cancer Imaging. 2012 Oct 26; 12:475-83. PMID: 23108260.
    Citations: 10     Fields:    Translation:Humans
  59. Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol. 2013 Jan; 39(1):46-52. PMID: 23084090.
    Citations: 11     Fields:    Translation:Humans
  60. Bauer DE, Kamran SC, Orkin SH. Reawakening fetal hemoglobin: prospects for new therapies for the ß-globin disorders. Blood. 2012 Oct 11; 120(15):2945-53. PMID: 22904296; PMCID: PMC4467860.
    Citations: 80     Fields:    Translation:Humans
  61. Kamran SC, Reichman DE, Missmer SA, Correia KF, Karaca N, Romano A, Racowsky C. Day 3 embryo shape as a morphologic selection parameter in in vitro fertilization. J Assist Reprod Genet. 2012 Oct; 29(10):1135-9. PMID: 22890423.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kamran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (238)
Explore
_
Co-Authors (129)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.